Maintenance Rituximab or Observation after Frontline Treatment with Bendamustine-Rituximab for Follicular Lymphoma

Bendamustine (B) with rituximab (R) is a standard frontline treatment for medically fit follicular lymphoma (FL) patients. The safety and efficacy of maintenance rituximab (MR) after BR induction has not been formally compared to observation for FL, resulting in disparate practice patterns. Prospect...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Br J Haematol
Hoofdauteurs: Hill, Brian T., Nastoupil, Loretta, Winter, Allison M., Becnel, Melody R., Cerhan, James R., Habermann, Thomas M., Link, Brian K., Maurer, Matthew J., Fakhri, Bita, Reddy, Prathima, Smith, Stephen D., Mukhija, Dhruvika, Jagadeesh, Deepa, Desai, Amrita, Alderuccio, Juan Pablo, Lossos, Izidore S., Mehra, Pooja, Portell, Craig A., Goldman, Max L., Calzada, Oscar, Cohen, Jonathon B., Hussain, Mohammad Junaid, Ghosh, Nilanjan, Caimi, Paolo, Tiutan, Timothy, Martin, Peter, Kodali, Abhigna, Evens, Andrew M., Kahl, Brad S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2018
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6486816/
https://ncbi.nlm.nih.gov/pubmed/30575016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15720
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items